Medication info
Mikatan Plus Tablet 40/12.5 mg

Mikatan Plus Tablet 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
SS Pharm Co., Ltd.
Appearance
Oval tablets with a white/pink two-layer structure, which may have pink speckles on the white layer.
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201000877 · Notified 2010.01.26 · Insurance code 652602820

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately according to the patient's needs. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is required.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
SS Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension when blood pressure is not adequately controlled with telmisartan alone. It effectively lowers blood pressure and helps prevent complications.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately according to the patient's needs. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dosage adjustment is required.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it could cause serious harm to the fetus. Avoid taking this medication if you are allergic to any of its ingredients or have certain liver or kidney diseases. Elderly patients, those with impaired liver function, and patients with heart diseases that have a risk of rapid blood pressure drop should use this medication with caution. This medication can cause electrolyte imbalances in the body; therefore, potassium and sodium levels should be monitored regularly while taking it. Skin reactions may occur, so it is advisable to reduce sun exposure and consult a doctor immediately if any abnormal symptoms develop. Interactions may occur with other medications; therefore, you must inform your doctor about any other prescriptions you are taking. Caution is required when driving or operating machinery, as dizziness or drowsiness may occur. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dehydration may appear, and you should go to the hospital immediately if these symptoms arise. This medication is not recommended for children, as its safety has not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 196 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • abnormal liver function
  • liver disorder
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • lumbar pain
  • muscle cramps
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • eczema
  • drug rash
  • toxic skin eruption
  • painful joints
  • renal dysfunction
  • weakness
  • increased blood creatinine
  • increased blood uric acid
  • increased creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitive reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal dysfunction
  • weakness
  • fever
  • nausea
  • abdominal pain
  • gastrointestinal bleeding
  • esophagitis
  • gastritis
  • dyspepsia
  • headache
  • tremor
  • facial flushing
  • lethargy
  • fatigue
  • anxiety
  • proteinuria
  • rash
  • lip and hand tremor
  • sensory hypersensitivity
  • vision deterioration
  • hypotension
  • tachycardia
  • bradycardia
  • orthostatic hypotension
  • dyspnea
  • cough
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • angioedema
  • erythema
  • urticaria
  • thrombocytopenia
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • anaphylactic reaction
  • hypokalemia
  • hyperlipidemia
  • hyponatremia
  • hyperuricemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • depression
  • sleep disorders
  • dizziness
  • paresthesia
  • headache
  • visual impairment
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal effusion
  • arrhythmia
  • orthostatic hypotension
  • necrotizing vasculitis
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • acute respiratory distress syndrome
  • diarrhea
  • nausea
  • vomiting
  • constipation
  • abdominal discomfort
  • pancreatitis
  • jaundice
  • cholestasis
  • rash
  • urticaria
  • photosensitive reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • muscle cramps
  • acute renal failure
  • diabetes
  • renal dysfunction
  • erectile dysfunction
  • weakness
  • fever
  • dizziness
  • diarrhea
  • cough
  • itching
  • myalgia
  • headache
  • floating sensation
  • cough
  • nausea
  • headache
  • gastrointestinal bleeding
  • esophagitis
  • fatigue
  • weight loss
  • proteinuria
  • headache
  • lip and hand tremor
  • sensory hypersensitivity
  • vision deterioration
  • hypoglycemia
  • intestinal angioedema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be kept between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Oval tablets with a white/pink two-layer structure, which may have pink speckles on the white layer.

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.